Discovering LINC00235: A Potential Drug Target (G64493)

Target Name: LINC00235

NCBI ID: G64493

LINC00235

Other Name(s): LA16c-356B8.1 | long intergenic non-protein coding RNA 235 | NCRNA00235 | Long intergenic non-protein coding RNA 235 | C16orf10

Discovering LINC00235: A Potential Drug Target

LINC00235 (LA16c-356B8.1) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. It is a member of the LINC (long non-coding RNA) family of proteins , which have been identified as potential drug targets in various diseases.

The discovery and characterization of LINC00235 was made by researchers at the University of California, San Diego, who used a variety of techniques to study its function and potential clinical applications. LINC00235 has been shown to play a role in a variety of physiological processes, including cell signaling, metabolism, and inflammation.

One of the key features of LINC00235 is its ability to interact with a variety of different proteins, including transcription factors, RNA-binding proteins, and signaling molecules. This interaction suggests that LINC00235 may be a key regulator of gene expression and that it may have a wide range of potential applications in both basic and clinical research.

In addition to its potential as a drug target, LINC00235 has also been shown to have a number of potential clinical applications. For example, it has been shown to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Additionally, LINC00235 has been shown to be involved in a number of different cellular processes that are important for human health, including the regulation of metabolism, inflammation, and stress responses.

Given the potential clinical applications of LINC00235, it is important to further study its function and properties. This can be done through a variety of techniques, including biochemical, cellular, and animal studies. In addition, there is a need for more research into the underlying mechanisms that regulate LINC00235 and its function. This may involve studies of its downstream targets, as well as its upstream regulators and interactions with other proteins.

Overall, LINC00235 is a promising drug target and has the potential to be a valuable tool for the study of a wide range of diseases. Further research is needed to fully understand its function and properties, and to develop its potential clinical applications.

Protein Name: Long Intergenic Non-protein Coding RNA 235

The "LINC00235 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00235 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets